Mirna Therapeutics Provides Operational Update and Reports Financial Results for Fourth Quarter and Full Year Ended December 31, 2015

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. ABBV
8. USO
9. MSFT
10. IBM

Go back to Mirna Therapeutics Provides Operational Update and Reports Financial Results for Fourth Quarter and Full Year Ended December 31, 2015

Leerink Partners Cuts Price Target on Mirna Therapeutics (MIRN) Following 4Q Updates

March 30, 2016 8:44 AM EDT

Leerink Partners maintained an Outperform rating on Mirna Therapeutics (NASDAQ: MIRN), and cut the price target to $10.00 (from $14.00), following the company's 4Q. MIRN ended 2015 with $89.7M in cash and equivalents, which should fund the company into 2018, according to management. MIRN reported that an additional... More